- Home
- EWTX vs LTC Comparison
EWTX vs LTC Comparison
Compare EWTX & LTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EWTX
- LTC
- Stock Information
- Founded
- EWTX 2017
- LTC 1992
- Country
- EWTX United States
- LTC United States
- Employees
- EWTX N/A
- LTC N/A
- Industry
- EWTX Biotechnology: Pharmaceutical Preparations
- LTC Real Estate Investment Trusts
- Sector
- EWTX Health Care
- LTC Real Estate
- Exchange
- EWTX Nasdaq
- LTC Nasdaq
- Market Cap
- EWTX 1.5B
- LTC 1.7B
- IPO Year
- EWTX 2021
- LTC 1992
- Fundamental
- Price
- EWTX $14.06
- LTC $35.53
- Analyst Decision
- EWTX Buy
- LTC Hold
- Analyst Count
- EWTX 9
- LTC 5
- Target Price
- EWTX $39.89
- LTC $38.80
- AVG Volume (30 Days)
- EWTX 804.3K
- LTC 301.3K
- Earning Date
- EWTX 11-06-2025
- LTC 10-27-2025
- Dividend Yield
- EWTX N/A
- LTC 6.41%
- EPS Growth
- EWTX N/A
- LTC N/A
- EPS
- EWTX N/A
- LTC 1.81
- Revenue
- EWTX N/A
- LTC $213,197,000.00
- Revenue This Year
- EWTX N/A
- LTC N/A
- Revenue Next Year
- EWTX N/A
- LTC $30.08
- P/E Ratio
- EWTX N/A
- LTC $19.70
- Revenue Growth
- EWTX N/A
- LTC 8.74
- 52 Week Low
- EWTX $10.60
- LTC $31.70
- 52 Week High
- EWTX $38.12
- LTC $39.89
- Technical
- Relative Strength Index (RSI)
- EWTX 46.82
- LTC 40.15
- Support Level
- EWTX $13.69
- LTC $36.29
- Resistance Level
- EWTX $15.16
- LTC $36.68
- Average True Range (ATR)
- EWTX 0.68
- LTC 0.43
- MACD
- EWTX -0.11
- LTC -0.11
- Stochastic Oscillator
- EWTX 17.81
- LTC 1.50
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
About LTC LTC Properties Inc.
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.